CVS Health stock: buy or sell?
July 16th, 2019
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail\u002FLTC segments.
Should I buy CVS Health stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, CVS Health stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is CVS Health stock a buy?
Banks and financial institutions post stock ratings everyday.At Stocks2.com, we gathered 15 ratings published for CVS stock in the last month.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-4-29||Credit Suisse Group||Outperform||Neutral|
|2019-4-10||Bank of America||n/a||Buy|
|2019-3-12||Sanford C. Bernstein||n/a||Outperform|
CVS Health stock analysis
Shares of CVS Health stayed steady a tight -0.10% and closed at $57.38.
Shares of CVS Health closed today at $57.38 and stayed stable a tight -0.10%. From a daily perspective, CVS is in a short term uptrend after plotting its last bottom ($54.65, on Wednesday) higher than the previous bottom, and its last top ($60.13, on Thursday) also over the previous top. Now trading in between its last bottom and last top CVS might consolidate in a plain range, waiting to break out over $60.13 or down under $54.65.
Shares of CVS Health stayed steady a bad -0.30% this week.
CVS Health stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since price and 40-weeks moving average lines crossed down by mid December 2018, CVS fell $-13.28 per share (-18.79%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average line is not recommended by many experts, as it indicates that the stock has not enough institutional support.
CVS Health stock price history
CVS Health stock historical price chart
CVS stock reached 52-week highs on November at $80.75, and all-time highs 2015-07-29 with a price of 103.64.
CVS Health stock price target is $73.20Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' CVS stock price predictions in the hope that they will be met as they may be wrong and not met. We have 12 price predictions for CVS Health stock published in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-5-2||UBS Group||Raises Target||$67.00||$74.00||10.4%|
|2019-5-2||UBS Group||Lowers Target||$74.00||$67.00||-9.5%|
|2019-5-2||Citigroup||Set Price Target||n/a||$74.00||-|
|2019-4-29||Morgan Stanley||Lowers Target||$92.00||$74.00||-19.6%|
|2019-4-18||Raymond James||Lowers Target||$90.00||$75.00||-16.7%|
|2019-4-10||SunTrust Banks||Lowers Target||$85.00||$65.00||-23.5%|
|2019-4-10||Bank of America||Lowers Target||$82.00||$74.00||-9.8%|
|2019-2-21||UBS Group||Lowers Target||$75.00||$74.00||-1.3%|
|2019-2-21||SunTrust Banks||Lowers Target||n/a||$85.00||-|
|2019-2-21||Loop Capital||Lowers Target||n/a||$68.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, CVS Health reported its latest financial data, posting a slightly good gain for the Earnings per Share (EPS). Experts expected $2.07 per share, but CVS Health posted $2.14.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, CVS Health annual turnover rose a fine 5.30% to $194,579.00 million dollars from $184,786.00 marked in 2017. When comparing 2018 vs 2017, nonetheless, profit margin (that is, the net income divided by revenues) declined a -3.89% to -0.31%.
|2013||$126,760 M||-||$4,600 M3.6%||-|
|2014||$139,367 M||9.95%||$4,644 M3.3%||0.96%|
|2015||$153,290 M||9.99%||$5,237 M3.4%||12.77%|
|2016||$177,526 M||15.81%||$5,317 M3.0%||1.53%|
|2017||$184,786 M||4.09%||$6,622 M3.6%||24.54%|
|2018||$194,579 M||5.30%||$-594.00 M-0.3%||-108.97%|
Quarterly financial resultsCVS Health posted $54,909.00 M in sales for 2018-Q4, a 16.16% improvement compared to previous quarter. Reported quarter earnings marked $-419.00 M with a profit margin of -0.76%. Profit margin depreciated a -3.70% compared to previous quarter when profit margin was 2.94%. When comparing turnover to same quarter last year, CVS Health sales marked an exceptional gain and rocketed a 13.48%. Looking back to recent quarterly results, CVS Health posted 3 positive quarters in a row.
|2017-Q2||$45,690 M||-||$1,090.00 M2.4%||-|
|2017-Q3||$46,181 M||1.07%||$1,285.00 M2.8%||17.89%|
|2017-Q4||$48,385 M||4.77%||$3,287.00 M6.8%||155.80%|
|2018-Q1||$45,693 M||-5.56%||$998.00 M2.2%||-69.64%|
|2018-Q2||$46,708 M||2.22%||$-2,563.00 M-5.5%||-356.81%|
|2018-Q3||$47,269 M||1.20%||$1,390.00 M2.9%||-154.23%|
|2018-Q4||$54,909 M||16.16%||$-419.00 M-0.8%||-130.14%|
|2019-Q1||$61,646 M||12.27%||$1,421.00 M2.3%||-439.14%|
CVS Health ownershipWhen you are planning to buy a company, it's worth to have a look its ownership structure.
CVS Health shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.24% of all shares.
Bearish positions for CVS stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to CVS Health:
|Market cap||$74.6 B||$353.4 M||$326.7 M||$51.0 B|
|Total shares||1,300.0 M||128.0 M||20.1 M||914.3 M|
|Float shares||1,300.0 M||108.5 M||17.6 M||753.8 M|
|- Institutional holdings (%)||83.8%||82.7%||104.8%||66.4%|
|- Insider holdings (%)||0.2%||0.8%||3.8%||16.1%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%|
CVS Health summary
|Tuesday, July 16th, 2019|
|Day range||$56.87 - $57.49|
|Average true range||$1.22|
|50d mov avg||$54.35|
|100d mov avg||$54.48|
|200d mov avg||$62.46|
CVS Health performanceTo better understand CVS Health performance you must becnhmark its gains with other related stocks in same sector or industry. For CVS Health, the benchmark is made against BioScrip, PetMed Express and Walgreens Boots Alliance.
|WBAWalgreens Boots A...||3.03%||-21.82%||-11.83%|
CVS Health competitorsOne check before investing in any stock is to review a list of its competitors, in this case for CVS Health. We picked 3 companies as CVS Health competitors as they are in the same industry or have similar market objectives.
Latest CVS Health stock news
- InvestorPlaceIf Everything is Going Wrong for CVS Health Stock, is That a Buy Signal?July 10, 2019
- InvestorPlace3 Big Stock Charts for Wednesday: CVS Health, Pfizer and WeyerhaeuserJuly 3, 2019
- InvestorPlaceCVS Health Stock Has Cannibalized ItselfJune 21, 2019
- Seeking Alpha3 Reasons CVS Health's Future Looks Bright Despite Current ChallengesJune 13, 2019
- InvestorPlace3 Reasons Why Patience On CVS Health Stock Could Pay Off For InvestorsJune 6, 2019